A multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy of immunosuppression in biopsy-proven virus-negative myocarditis or inflammatory cardiomyopathy
(IMPROVE-MC).
RecruitingCTIS2024-517484-23-00
Medical University Of Warsawinflammatory cardiomyopathy, Myocarditis
Start: 2022-07-26Target: 100Updated: 2024-11-05